Target intelligence / Profile preview

NF-kappa-B inhibitor-interacting Ras-like protein 2 (NKIRAS2)

Target
NKIRAS2
Molecular classification
Small GTPase (Ras superfamily, atypical Ras-like protein), Intracellular signaling protein
01

Overview

NF-kappa-B inhibitor-interacting Ras-like protein 2 (NKIRAS2) is an atypical Ras-like small GTPase that acts as a potent regulator of NF-kappa-B activity in human cells[6][1][5]. Unlike classical Ras proteins, NKIRAS2 associates with inhibitors of NF-kappa-B (notably NFKBIB/IκBβ) and prevents their signal-induced degradation. This stabilizes NF-kappa-B inhibitors and suppresses the transcriptional activation of NF-kappa-B target genes, thereby modulating inflammatory responses and potentially playing roles in tumorigenesis and other disease states related to chronic NF-kappa-B activation. NKIRAS2 is both nuclear and cytoplasmic and is structurally related to other Ras family GTPases, although it differs functionally by acting as a negative regulator in the NF-kappa-B signaling pathway rather than stimulating proliferation or cell survival[6][1][5].

Other names
NF-kappa-B inhibitor-interacting Ras-like 2NFKB inhibitor interacting Ras like 2NKIRAS2KBRAS2Kappa B-Ras protein 2KappaB-Ras2kappaB-Ras2I-kappa-B-interacting Ras-like protein 2NFKB inhibitor interacting Ras-like protein 2DKFZP434N1526
02

Biological functions

Regulation of NF-kappa-B activityPrevention of degradation of NF-kappa-B inhibitor beta (NFKBIB)Modulation of signal transduction
03

Disease associations

Cancer (implicated through regulation of NF-kappa-B signaling, which is broadly linked to inflammation and oncogenesis)Inflammation (by modulating NF-kappa-B pathway)

Beyond the preview

Go deeper on NF-kappa-B inhibitor-interacting Ras-like protein 2 (NKIRAS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NF-kappa-B inhibitor-interacting Ras-like protein 2 (NKIRAS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call